J Nanobiotechnology April 2023 PMID 37069614

Phase-transition nanodroplets with immunomodulatory capabilities for potentiating mild magnetic hyperthermia to inhibit tumour proliferation and metastasis.

Qiaoxi Qin, Yang Zhou, Pan Li, Ying Liu, Ruxi Deng, Rui Tang, Nianhong Wu, Li Wan, Ming Ye, Hong Zhou, Zhiming Wang

Full text PDF Download social card

Mentions

Peak: 3 in Apr 2023

across 2 sources since Apr 2023

Extended reach

433

potential audience

Total likes

Video views

Mentions per month

Apr 2023 – Jul 2023

Where it's discussed

X / Twitter3 posts
YouTube1 videos

AI synopsis

What people are saying

The discussions reflect a high level of interest and agreement, with posts referencing the hybrid nanodroplet system's ability to enhance safety and efficacy in hyperthermia treatments, using positive language like 'promising' and 'innovative'. The tone is optimistic and emphasizes the potential breakthrough in reducing side effects and boosting immune responses, indicating awareness of the publication’s significance.

AgreementModerate agreement

Most discussions express strong support and alignment with the publication's findings and potential applications.

InterestHigh interest

Posts demonstrate high interest, highlighting innovations and promising implications for cancer treatment.

EngagementModerate engagement

Several discussions delve into mechanisms and potential benefits, showing moderate depth of engagement.

ImpactModerate impact

The shared enthusiasm suggests recognition of meaningful contributions to nanomedicine and cancer therapy.

Abstract in brief

This study introduces a hybrid nanosystem called SPIOsRPPs, designed to improve magnetic hyperthermia (MHT) therapy for tumors by lowering the temperature needed for treatment, reducing damage to healthy tissues, and boosting immune response to prevent tumor growth and spread.
These nanodroplets contain immune-stimulating agents and phase transition materials that produce microbubbles, which help decrease the temperature threshold from 50°C to about 44°C, enhancing the therapy’s safety and effectiveness while promoting immune activation like increased calreticulin exposure and dendritic cell maturation.
The combined approach of mild hyperthermia and immune stimulation significantly inhibits tumor growth and metastasis, especially in the lungs, suggesting a promising new strategy for safer and more effective cancer treatment.]

Read the full abstract

All mentions

Nanodroplets Enhancing Mild Hyperthermia and Immune Response in Cancer Therapy

This study introduces SPIOsRPPs nanodroplets designed to enhance magnetic hyperthermia therapy by lowering required temperatures, reducing damage to healthy tissues, and boosting immune activation to inhibit tumor…

STEM RTCL TV · Jul 17, 2023 6 views

technews

@TechNewsss03 · X

Phase-transition nanodroplets with immunomodulatory capabilities for potentiating mild magnetic hyperthermia to inhibit tumour proliferation and metastasis | Journal of Nanobiotechnology https://t.co/COgpxs9c0U

Apr 20, 2023 · 45 followers View post →

Dendritic Cell Papers

@DenCell_Papers · X

Phase-transition nanodroplets with immunomodulatory capabilities for potentiating mild magnetic hyperthermia to inhibit tumour proliferation and metastasis https://t.co/CqcAwVLUry

Apr 19, 2023 · 86 followers View post →

Hammed Onilude (PhD)

@HammedOnilude · X

Phase-transition nanodroplets with immunomodulatory capabilities for potentiating mild magnetic hyperthermia to inhibit tumour proliferation and metastasis https://t.co/EvdAu62wqP

Apr 17, 2023 · 296 followers View post →